Company Overview

Company Overview

Welcome to Cliantha Research, a global Contract Research Organization (CRO) providing integrated clinical offerings in Early Phase (Phase I/IIa), Late Phase (Phase II-IV), Bioequivalence (BA/BE), Clinical Endpoint Trials, Bioanalytical, Biosimilars, Dermatology, Respiratory, Allergy, Biometrics, and Personal Healthcare services. Our services have science at its foundation that is developed through regular and systematic training of the Cliantha Team.

Cliantha offers Biosimilar, Biotech, Cosmetic, Generic, Personal Healthcare and Pharmaceutical companies a comprehensive range of clinical research and support services. You will notice we use our legacy brand names: Cliantha Research, Hill Top Research, Inflamax Research and Karmic Lifesciences, however, we operate as one company – Cliantha. We have added and enhanced the capabilities during the past 6 years in each of the companies to provide our sponsors with a single, global research network.

Our Strength

  • Science and Integrity are the foundation of the research conducted by Cliantha.
  • Our e-Learning management system tracks GLP, GCP and SOP training of our team members.
  • We have an international presence including India, Canada and the US.
  • Our Senior Management team has an average of 18 years of CRO, Industry, and Academic experience.
  • Successfully conducted more than 5000 studies globally.
  • Service Biometrics on major platforms including kTrialsTM.
  • Standard setting Phase I-IV dermatology expertise for 70 years (Hill Top Research)
  • Analyzed more than 2 million bioanalytical samples to support marketing authorizations around the globe.

Regulatory Inspections

Last Inspection in Nov 2015
Inspected facility in Nov 2006
Inspected facility in Jan 2009
Last inspection in March 2017
Last inspection in April 2017
Last inspection in March 2013
Inspected facility in July 2013
Last inspected by Ministry of Health of Turkey in April 2013
Last inspection in April 2011